DK173201B1 - Anvendelse af glycerylestere af monocarboxylsyrer til fremstilling af dermatologiske formuleringer og fremstilling af et fa - Google Patents

Anvendelse af glycerylestere af monocarboxylsyrer til fremstilling af dermatologiske formuleringer og fremstilling af et fa Download PDF

Info

Publication number
DK173201B1
DK173201B1 DK199101594A DK159491A DK173201B1 DK 173201 B1 DK173201 B1 DK 173201B1 DK 199101594 A DK199101594 A DK 199101594A DK 159491 A DK159491 A DK 159491A DK 173201 B1 DK173201 B1 DK 173201B1
Authority
DK
Denmark
Prior art keywords
acid
skin
use according
compound
decaglycerol
Prior art date
Application number
DK199101594A
Other languages
Danish (da)
English (en)
Other versions
DK159491A (da
DK159491D0 (da
Inventor
Carl Richard Thornfeldt
Original Assignee
Thornfeldt Carl R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thornfeldt Carl R filed Critical Thornfeldt Carl R
Publication of DK159491A publication Critical patent/DK159491A/da
Publication of DK159491D0 publication Critical patent/DK159491D0/da
Application granted granted Critical
Publication of DK173201B1 publication Critical patent/DK173201B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soil Working Implements (AREA)
  • Agricultural Machines (AREA)
DK199101594A 1989-03-13 1991-09-12 Anvendelse af glycerylestere af monocarboxylsyrer til fremstilling af dermatologiske formuleringer og fremstilling af et fa DK173201B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8901005 1989-03-13
PCT/US1989/001005 WO1990010441A1 (fr) 1989-03-13 1989-03-13 Traitement des maladies et tumeurs de la peau

Publications (3)

Publication Number Publication Date
DK159491A DK159491A (da) 1991-09-12
DK159491D0 DK159491D0 (da) 1991-09-12
DK173201B1 true DK173201B1 (da) 2000-03-13

Family

ID=22214880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199101594A DK173201B1 (da) 1989-03-13 1991-09-12 Anvendelse af glycerylestere af monocarboxylsyrer til fremstilling af dermatologiske formuleringer og fremstilling af et fa

Country Status (8)

Country Link
EP (2) EP0462964B1 (fr)
JP (1) JP2513877B2 (fr)
KR (1) KR960016205B1 (fr)
AT (1) ATE168557T1 (fr)
AU (1) AU641356B2 (fr)
DE (1) DE68928756T2 (fr)
DK (1) DK173201B1 (fr)
WO (1) WO1990010441A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
DE4237081C2 (de) * 1992-11-03 1996-05-09 Beiersdorf Ag Verwendung von Di- oder Triglycerinestern als Deowirkstoffe
DE4237367C2 (de) * 1992-11-05 1995-10-12 Beiersdorf Ag Verwendung von Fettsäureestern in kosmetischen oder dermatologischen Zubereitungen
DE4305069C3 (de) * 1993-02-19 1999-02-25 Beiersdorf Ag Verwendung von Monocarbonsäureestern des Diglycerins als wirksames Prinzip gegen unreine Haut und/oder gegen Propionibacterium acnes
CA2278123A1 (fr) * 1997-01-24 1998-07-30 Karen Hanley Utilisation d'activateurs de fxr, ppar.alpha. et lxr.alpha. dans le but de restaurer la fonction de barriere, de favoriser la differenciation epidermique et d'inhiber la proliferation epidermique
ES2369473T3 (es) 2004-10-07 2011-12-01 Actamax Surgical Materials Llc Adhesivo tisular polimérico basado en polisacárido para uso médico.
JP5539725B2 (ja) 2006-11-27 2014-07-02 アクタマックス サージカル マテリアルズ リミテッド ライアビリティ カンパニー 分岐末端反応物及びそれから製造されるポリマーヒドロゲル組織接着剤
US8426492B2 (en) 2007-11-14 2013-04-23 Actamax Surgical Materials, Llc Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
TWI448290B (zh) * 2007-12-19 2014-08-11 Prometic Biosciences Inc 與健擇他濱（ｇｅｍｃｉｔａｂｉｎｅ）組合用於胰臟癌之治療的中等鏈長脂肪酸、鹽類及三酸甘油酯
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
US9044529B2 (en) 2008-11-19 2015-06-02 Actamax Surgical Materials, Llc Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
EP2416811B1 (fr) 2009-04-09 2015-09-09 Actamax Surgical Materials LLC Adhésif de type hydrogel pour tissus, ayant un temps de dégradation réduit
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
WO2011002956A1 (fr) 2009-07-02 2011-01-06 E. I. Du Pont De Nemours And Company Polysaccharides fonctionnalisés par aldéhyde
JP2013538866A (ja) * 2010-10-06 2013-10-17 バイオ スキンケア リミテッド 皮膚治療のための組成物
WO2012046046A1 (fr) * 2010-10-06 2012-04-12 Bio Skincare Limited Composition pour le traitement de la peau
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
US20160184474A1 (en) 2013-07-29 2016-06-30 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations
KR102104305B1 (ko) * 2014-08-13 2020-04-24 주식회사 엘지생활건강 모노미리스틴 또는 이의 약학적으로 허용가능한 염을 포함하는 흑화, 탄력, 주름개선, 보습 또는 항염증용 화장료 또는 약학 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081232A (en) * 1960-12-27 1963-03-12 Warner Lambert Pharmaceutical Iodine preparation and method of disinfecting the skin
US3987198A (en) * 1973-10-16 1976-10-19 Syntex (U.S.A.) Inc. Method for lowering the free fatty acid content in sebum using certain fatty acid amides
US4025645A (en) * 1976-01-27 1977-05-24 Jelenko Iii Carl Non-steroid topical agent for alleviating inflammation in mammals
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
GB8514975D0 (en) * 1985-06-13 1985-07-17 Sempernova Plc Compositions
GB2179249A (en) * 1985-08-24 1987-03-04 Smith & Nephew Ass Dispensing filled pressurised container
GB8600822D0 (en) * 1986-01-15 1986-02-19 Unilever Plc Treatment of skin disorders
CA1302280C (fr) * 1986-04-21 1992-06-02 Jon Joseph Kabara Compositions et methodes pharmaceutiques antimicrobiennes topiques
GB8620896D0 (en) * 1986-08-29 1986-10-08 Unilever Plc Cosmetic composition
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
DE3905325A1 (de) * 1989-02-17 1990-09-06 Schering Ag Hydroxyalkancarbonsaeure-derivate, deren herstellung und verwendung

Also Published As

Publication number Publication date
KR960016205B1 (ko) 1996-12-06
DK159491A (da) 1991-09-12
DE68928756T2 (de) 1999-03-04
KR920702818A (ko) 1992-10-28
DK159491D0 (da) 1991-09-12
AU641356B2 (en) 1993-09-23
ATE168557T1 (de) 1998-08-15
AU3531989A (en) 1990-10-09
EP0462964A1 (fr) 1992-01-02
EP0839529A2 (fr) 1998-05-06
JP2513877B2 (ja) 1996-07-03
JPH04504562A (ja) 1992-08-13
WO1990010441A1 (fr) 1990-09-20
EP0462964B1 (fr) 1998-07-22
EP0462964A4 (en) 1993-02-10
DE68928756D1 (de) 1998-08-27
EP0839529A3 (fr) 2000-03-22

Similar Documents

Publication Publication Date Title
DK173201B1 (da) Anvendelse af glycerylestere af monocarboxylsyrer til fremstilling af dermatologiske formuleringer og fremstilling af et fa
CA2074493C (fr) Traitement des demangeaisons a l'aide d'esters et d'amides
JP2538516B2 (ja) 顔面前癌状態又は脂漏性面疾患の治療剤
KR20170139003A (ko) 지방 조직의 저감
UA76415C2 (uk) Застосування похідних бігуаніду для отримання лікарського препарату з ефектом загоєння ран
US20140302185A1 (en) Composition for the treatment of skin lesions
FRY et al. Effect of Eetinoic acid in psoriasis
KR20200136990A (ko) 서방형 마취제 조성물 및 이의 제조 방법
WO2013088380A1 (fr) Compositions de gel
AU2012364664A1 (en) Gel compositions
US4868219A (en) Treatment of skin diseases with aliphatic amines
US20140343141A1 (en) Topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture
BR112013033169B1 (pt) Composição que compreende um primeiro extrato de cebola (a) e lipossomas e método para a preparação de uma composição
KR0145678B1 (ko) 트리글리세라이드를 함유하는 포도필로톡신 제제
US20220296618A1 (en) Anti-inflammatory compounds for use in the treatment of dermal disorders
US20130197089A1 (en) Compositions for the treatment of actinic keratosis
CN110368358B (zh) 一种辛伐他汀的外用制剂及其应用
EP2931250A1 (fr) Compositions de gel
EP2790672A1 (fr) Compositions de gel
CA1317884C (fr) Traitement des affections et des tumeurs de la peau
US5061733A (en) Tetrahydronaphthalene and indane compounds useful for reversing the photodamage in sun-exposed skin
Otani Topically Applied Griseofulvin
JP2013542208A (ja) 皮膚の治療用組成物

Legal Events

Date Code Title Description
PBP Patent lapsed
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK